Ivermectin for COVID-19; to use or not to use?

  • Yasuhiro Morimoto Department of Anesthesia, Ube Industries Central Hospital, Ube Yamaguchi, Japan.
Keywords: COVID-19, Pandemic, Mortality, Prevention, Ivermectin

Abstract

COVID-19 has engulfed the continents into a pandemic, filling the hospitals with this viral disease, heavily taxing the healthcare facilities and claiming thousands of lives in almost every country. In the absence of a known evidence-based remedy, many treatment options have been tried with variable results. Multiple vaccines have been developed by the drug industry, but none can be claimed to be 100% effective in prevention of the disease. There has been some evidence about the beneficial effects of ivermectin – an anthelmintic drug. This editorial discusses the various aspects of the use of ivermectin for the treatment of active COVID-19.

Key words: COVID-19; Pandemic; Mortality; Prevention; Ivermectin

Citation: Morimoto Y. Ivermectin for COVID-19; to use or not to use? Anaesth. pain intensive care 2021;25(5):562–564; DOI: 10.35975/apic.v25i5.1651

Published
05-10-2021
How to Cite
Morimoto, Y. (2021). Ivermectin for COVID-19; to use or not to use?. Anaesthesia, Pain & Intensive Care, 25(5), 566-568. https://doi.org/10.35975/apic.v25i5.1651
Section
Editorial Views